Evidence map›Paper›PMID 39597394›Full record

ArticleMaterials (Basel, Switzerland)2024

Utilisation of By-Product Phosphogypsum Through Extrusion-Based 3D Printing.

Maris Sinka, Danutė Vaičiukynienė, Dalia Nizevičienė, Alise Sapata, Ignacio Villalón Fornés, Vitoldas Vaitkevičius, Evaldas Šerelis

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Influence of NaMaterials (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maris SinkaInstitute of Materials and Structures, Faculty of Civil Engineering, Riga Technical University, Kipsalas St. 6A, LV-1658 Riga, Latvia.ORCID 0000-0002-2332-1347
Danutė VaičiukynienėBuilding Materials and Structures Research Centre, Faculty of Civil Engineering and Architecture, Kaunas University of Technology, Studentu St. 48, LT-51367 Kaunas, Lithuania.ORCID 0000-0001-8176-4413
Dalia NizevičienėDepartment of Electrical Power Systems, Faculty of Electrical and Electronics Engineering, Kaunas University of Technology, Studentu St. 48, LT-51367 Kaunas, Lithuania.
Alise SapataInstitute of Materials and Structures, Faculty of Civil Engineering, Riga Technical University, Kipsalas St. 6A, LV-1658 Riga, Latvia.ORCID 0009-0007-1221-2026
Ignacio Villalón FornésBuilding Materials and Structures Research Centre, Faculty of Civil Engineering and Architecture, Kaunas University of Technology, Studentu St. 48, LT-51367 Kaunas, Lithuania.ORCID 0000-0002-1606-9438
Vitoldas VaitkevičiusBuilding Materials and Structures Research Centre, Faculty of Civil Engineering and Architecture, Kaunas University of Technology, Studentu St. 48, LT-51367 Kaunas, Lithuania.
Evaldas ŠerelisBuilding Materials and Structures Research Centre, Faculty of Civil Engineering and Architecture, Kaunas University of Technology, Studentu St. 48, LT-51367 Kaunas, Lithuania.ORCID 0000-0002-8059-0308

Funding

Fundamental and Applied Research Projects lzp-2022/1-0585
6 · The paper itself

Abstract

Phosphogypsum (PG) is a phosphate fertiliser by-product. This by-product has a low level of utilisation. Calcium sulphate is dominated in PG similar to gypsum and, therefore, has good binding properties (similar to natural gypsum). However, the presence of water-soluble phosphates and fluorides, an unwanted acidic impurity in PG, makes PG unsuitable for the manufacture of gypsum-based products. In this study, the binding material of PG (β-CaSO

Indexed as

3D printingbuilding materialsphosphogypsumrecycling materials

Identifiers

PMID39597394
PMCPMC11595359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.